Todd Rice, MD
Critical Care Medicine · Nashville, TNNPI 1558458687
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $276,822 of the $291,260 with a category attached, or 95.0%. Cumberland Pharmaceuticals, Inc. accounts for 75.7% of it on its own, with 10 other manufacturers making up the rest. Among critical care medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $2510.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cumberland Pharmaceuticals, Inc.$220K
- Sanofi US Services Inc.$43K
- AstraZeneca$18K
- Baxter Healthcare$7K
- Cytovale, Inc.$2K
- Janssen Research & Development, LLC$450
- plus $225 from 5 others
Across 18 payments — averaging $17,566 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$280K
- Biotest AG$36K
- Cerus Corporation$799
Across 2 payments — averaging $19,000 each. An ownership or investment interest held by the physician or an immediate family member.
- Cumberland Pharmaceuticals, Inc.$38K
What the payments were for
- Consulting fees$276,82295%
- Speaking & faculty fees$13,7625%
- Travel & lodging$1550%
- Food & beverage$5050%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cumberland Pharmaceuticals, Inc. | 77 | $220,430 |
| Sanofi US Services Inc. | 15 | $43,341 |
| AstraZeneca | 10 | $18,000 |
| Baxter Healthcare | 7 | $7,314 |
| Cytovale, Inc. | 1 | $1,500 |
| Janssen Research & Development, LLC | 1 | $450 |
| Fresenius Kabi USA, LLC | 1 | $153 |
| Solventum Corporation | 1 | $20 |
| Atricure, Inc. | 1 | $18 |
| Vapotherm Inc | 1 | $18 |
| Insmed, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Caldolor$167,074
- Kristalose$166,963
- Vibativ$166,963
- Vaprisol Dextrose in Plastic Container$166,963
- SANCUSO$137,338
- RediTrex$29,625
- IPS - Nutrition$7,160
- Smoflipid$153
How this compares
$291,260 in reported general payments places this provider in the 95th percentile of 141 critical care medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Nashville
- Gordon BernardNashville$730K
- Jamie DeneauNashville$33K
- Ann GageNashville$22K
- Lorraine WareNashville$18K
- Shelton HarrellNashville$16K
- Joseph SchlesingerNashville$15K
- Angelo CanonicoNashville$15K
- Erik HessNashville$14K
- Jonathan CaseyNashville$13K
- Eugene ElyNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.